Equities
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)67.77
  • Today's Change0.00 / 0.00%
  • Shares traded868.86k
  • 1 Year change-7.00%
  • Beta0.5476
Data delayed at least 15 minutes, as of Apr 25 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CVS Health Corporation is a health solutions company. The Company operates in four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Its Health Care Benefits segment offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services segment provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services, including pharmacy patient care programs, diagnostic testing and vaccination administration.

  • Revenue in USD (TTM)357.78bn
  • Net income in USD8.34bn
  • Incorporated1996
  • Employees300.00k
  • Location
    CVS Health Corp1 Cvs DrWOONSOCKET 02895-6146United StatesUSA
  • Phone+1 (401) 765-1500
  • Fax+1 (302) 655-5049
  • Websitehttps://cvshealth.com/
More ▼

Institutional shareholders

32.83%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 2023111.97m8.90%
BlackRock Fund Advisorsas of 31 Dec 202358.78m4.67%
SSgA Funds Management, Inc.as of 31 Dec 202355.20m4.39%
Capital Research & Management Co. (World Investors)as of 31 Dec 202340.54m3.22%
Capital Research & Management Co. (International Investors)as of 31 Dec 202333.69m2.68%
Dodge & Coxas of 31 Dec 202330.41m2.42%
Fidelity Management & Research Co. LLCas of 31 Dec 202325.72m2.04%
Geode Capital Management LLCas of 31 Dec 202324.51m1.95%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 202318.44m1.47%
Norges Bank Investment Managementas of 31 Dec 202313.83m1.10%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.